Martin Babler

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Martin Babler
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Martin Babler:

Company Role Class Num Shares Value Price $ Report Date Ownership
ALUMIS INC. President, CEO and Chairman, Director Common Stock 106,454 $474,784 $4.46 29 Jul 2025 By Trust
ALUMIS INC. President, CEO and Chairman, Director Common Stock 3,000 $13,380 $4.46 29 Jul 2025 Direct
ALUMIS INC. President, CEO and Chairman, Director Stock Option (Right to Buy) 150,000 29 Jul 2025 Direct
Prelude Therapeutics Inc Director Director Stock Option (Right to Buy) 38,000 12 Jun 2025 Direct
Neoleukin Therapeutics, Inc. Director Stock Option (Right to Buy) 25,000 08 Jun 2023 Direct
89bio, Inc. Director Stock Option (Right to Buy) 0 30 Oct 2025 Direct

Insider Reports Filed by Martin Babler

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ETNB 89bio, Inc. 30 Oct 2025 2 $0 4 Director 30 Oct 2025, 20:14
ALMS ALUMIS INC. 29 Jul 2025 2 $0 4 President, CEO and Chairman, Director 31 Jul 2025, 21:05
PRLD Prelude Therapeutics Inc 12 Jun 2025 1 $0 4 Director 13 Jun 2025, 16:13
ALMS ALUMIS INC. 01 Apr 2025 1 +$100,733 4 President, CEO and Chairman, Director 03 Apr 2025, 18:05
ALMS ALUMIS INC. 18 Feb 2025 1 $0 4 President, CEO and Chairman, Director 20 Feb 2025, 18:30
ETNB 89bio, Inc. 03 Feb 2025 1 $0 4 Director 05 Feb 2025, 16:01
ALMS ALUMIS INC. 27 Jun 2024 21 $0 4 President, CEO and Chairman, Director 01 Jul 2024, 16:35
ALMS ALUMIS INC. 27 Jun 2024 0 $0 3 President, CEO and Chairman, Director 27 Jun 2024, 16:02
PRLD Prelude Therapeutics Inc 14 Jun 2024 1 $0 4 Director 18 Jun 2024, 16:11
ETNB 89bio, Inc. 02 May 2024 1 $0 4 Director 03 May 2024, 16:01
ETNB 89bio, Inc. 13 Apr 2024 0 $0 3 Director 23 Apr 2024, 16:01
PRLD Prelude Therapeutics Inc 16 Jun 2023 1 $0 4 Director 21 Jun 2023, 16:11
NGNE Neoleukin Therapeutics, Inc. 08 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:24
PRLD Prelude Therapeutics Inc 17 Jun 2022 1 $0 4 Director 22 Jun 2022, 16:13
NGNE Neoleukin Therapeutics, Inc. 12 May 2022 1 $0 4 Director 16 May 2022, 18:22
PRLD Prelude Therapeutics Inc 19 Jul 2021 1 $0 4 Director 20 Jul 2021, 20:30
PRLD Prelude Therapeutics Inc 19 Jul 2021 0 $0 3 Director 20 Jul 2021, 20:26
NGNE Neoleukin Therapeutics, Inc. 11 May 2021 1 $0 4 Director 13 May 2021, 17:36